Stock AnalizCardinal Health (CAH) earnings for the quarter ended September 2026: EPS beats estimates
Cardinal Health reported results for the quarter ended September 2026 on November 5, 2026. Adjusted earnings per share came in at $3.26 against the analysts’ average forecast of $2.94, a beat of 10.9%.
Revenue for the quarter was $67.51 billion, up 5.5% from $64.01 billion in the same quarter a year earlier.
The market’s verdict: the stock rose 3.7% on the first trading day after the report.
The last four quarters
Cardinal Health has beaten the analysts’ EPS forecast in 4 of the last 4 quarters.
| Quarter | EPS | Forecast | Surprise | Revenue growth | Price reaction |
|---|---|---|---|---|---|
| Sep 2026 | $3.26 | $2.94 | +10.9% | +5% | +3.7% |
| Jun 2026 | $2.60 | $2.42 | +7.4% | — | −1.3% |
| Mar 2026 | $3.17 | $2.79 | +13.7% | — | −3.7% |
| Dec 2025 | $2.63 | $2.37 | +11.2% | +19% | +9.4% |
What comes next
Analysts expect EPS of $3.13 for the next quarter on average and $13.00 for the fiscal year ending June 30, 2027.
The average analyst price target is $294.87, 5% above the current price of $281.10.
Valuation and score
Cardinal Health scores 3.4 out of 5 overall on Stock Analiz (good, with some weak spots), trades at a trailing P/E of about 36.4, and its intrinsic value under moderate assumptions is about 16% above the current market value. Full Cardinal Health analysis with 10 years of financials
Frequently asked questions
What was Cardinal Health’s EPS for the quarter ended September 2026?
$3.26 adjusted per share, against an analyst consensus of $2.94.
How much revenue did Cardinal Health report?
$67.51 billion, up 5.5% year over year.
More
This report was written automatically from the published numbers within hours of the release. It is information, not investment advice.